Medication Description: Survanta
The active ingredient is a surfactant beraktant, which reduces the surface tension in the walls of the alveoli and thus prevents them from falling off while reducing transpulmonary pressure.
Apply, like kurosurfu and exosurf, with respiratory distress syndrome in preterm infants.
Intracartaalum is administered in a dose of 4 ml / kg under artificial respiration conditions.
Product form: 2.5% suspension in single-use vials of 8 ml.
Surfactants are a relatively new group of drugs. A number of modern preparations of this group have been created (surasurf from light calves and pigs, semi-synthetic substances, etc.), which are currently in the stage of in-depth study.